We aim to assemble the evidence in a concise format that enhances clinicians’ real-life decision-making with individual patients. The project consists of 4 publications: part 1 concisely summarizes the evidence and provides a framework to guide clinical decision-making, part 2 reviews the body of evidence regarding surgery in generally healthy patients, part 3 addresses specific patients and tumors, part 4 focuses on evidence regarding SBRT and ablation.
Prof. Frank C. Detterbeck: A Summary That Was Nuanced Enough to Guide Decision-Making for Individual Patients
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 1: a guide to decision-making
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation
Disclosure:
The series “A Guide for Managing Patients with Stage I NSCLC: Deciding between Lobectomy, Segmentectomy, Wedge, SBRT and Ablation” was commissioned by the editorial office, Journal of Thoracic Disease without any funding or sponsorship. Frank C. Detterbeck served as the unpaid Guest Editor for the series.